A phase II study of bortezomib in patients with MALT lymphoma.
Troch M, Jonak C, Müllauer L, Püspök A, Formanek M, Hauff W, Zielinski CC, Chott A, Raderer M.
Troch M, et al. Among authors: chott a.
Haematologica. 2009 May;94(5):738-42. doi: 10.3324/haematol.2008.001537. Epub 2009 Mar 31.
Haematologica. 2009.
PMID: 19336742
Free PMC article.
Clinical Trial.